sunesis pharmaceuticals inc
(SNSS:NASDAQ CM)
As of 8:10 PM 06/19/13 All times are local (Market data is delayed by at least 15 minutes).
Financial Statements for sunesis pharmaceuticals inc (SNSS)
Year over year, Sunesis Pharmaceuticals, Inc. has seen revenues fall from $5.0M USD to $3.8M USD. This along with an increase in SGA costs has led to a reduction in the bottom line from a loss of $20.1M USD to an even larger loss of $44.0M USD.
| Currency in Millions of US Dollars | As of: | Dec 31 2009 Restated | Dec 31 2010 Restated | Dec 31 2011 | Dec 31 2012 | 4 Year Trend |
| Revenues | 3.8 | 0.0 | 5.0 | 3.8 |  | |
| TOTAL REVENUES | 3.8 | 0.0 | 5.0 | 3.8 | | |
| GROSS PROFIT | 3.8 | 0.0 | 5.0 | 3.8 | | |
| Selling General & Admin Expenses, Total | 7.7 | 7.0 | 8.3 | 9.2 | | |
| R&D Expenses | 13.2 | 14.4 | 22.6 | 29.2 | | |
| OTHER OPERATING EXPENSES, TOTAL | 21.0 | 21.4 | 30.9 | 38.4 | | |
| OPERATING INCOME | -17.2 | -21.4 | -25.9 | -34.6 | | |
| Interest Expense | -- | -- | -0.3 | -1.9 | | |
| Other Non-Operating Expenses, Total | -0.1 | -3.2 | 6.0 | -7.5 | | |
| Other Non-Operating Income (Expenses) | -0.1 | -3.2 | 6.0 | -7.5 | | |
| Merger & Restructuring Charges | -1.9 | -- | -- | -- | | |
| Other Unusual Items, Total | -21.0 | -- | -- | -- | | |
| EBT, INCLUDING UNUSUAL ITEMS | -40.2 | -24.6 | -20.1 | -44.0 | | |
| Earnings from Continuing Operations | -40.2 | -24.6 | -20.1 | -44.0 | | |
| NET INCOME | -40.2 | -24.6 | -20.1 | -44.0 | | |
| NET INCOME TO COMMON INCLUDING EXTRA ITEMS | -67.8 | -24.6 | -20.1 | -44.0 | | |
| NET INCOME TO COMMON EXCLUDING EXTRA ITEMS | -67.8 | -24.6 | -20.1 | -44.0 | | |
| Recently Viewed | |||
| SNSS:US | $5.21 USD | +0.10 |  |
| Company | Last | Change |
| BioDelivery Sciences International Inc | $4.53 USD | -0.13 |
| EpiCept Corp | $0.07 USD | +0.01 |
| NeurogesX Inc | $0.01 USD | -0.0009 |
| Pozen Inc | $4.96 USD | -0.16 |
| View Industry Companies | ||
Industry Analysis
SNSS
Industry Average
| Valuation | SNSS | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 45.9x |
|
| Price/Book | 238.9x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 31.1x |
|
Post a JobJobs
- Chicago, IL | DunnhumbyusaPosted: Jun 18
- Thomasville, GA | Flowers FoodsPosted: Jun 07
- San Francisco, CA | YelpPosted: Jun 06
- San Francisco, CA | PeoplematterPosted: Jun 06
